Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis

被引：0

作者：

Lam, Michael ^{[1
]}

Olivier, Timothee

Haslam, Alyson ^{[3
]}

Tuia, Jordan ^{[3
]}

Prasad, Vinay ^{[2
,3
,4
]}

机构：

[1] Univ Calif La Jolla, 9500 Gilman Dr, San Diego, CA 92093 USA

[2] Geneva Univ Hosp, Dept Oncol, 4 Gabrielle Perret Gentil St, CH-1205 Geneva, Switzerland

[3] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA

[4] Mission Hall Global Hlth Clin Sci Bldg, Dept Epidemiol & Biostat, 550 16th St,2nd Fl, San Francisco, CA 94158 USA

来源：

EUROPEAN JOURNAL OF CANCER | 2024年 / 202卷

关键词：

D O I：

10.1016/j.ejca.2024.114019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[31] How Cost-of-Illness Studies Can be Made More Useful for Illicit Drug Policy Analysis
Moore, Timothy J.
Caulkins, Jonathan P.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2006, 5 (02) : 75 - 85
[32] The complex effects of demographic history on the estimation of substitution rate: concatenated gene analysis results in no more than twofold overestimation
Martin, Christopher H.
Hoehna, Sebastian
Crawford, Jacob E.
Turner, Bruce J.
Richards, Emilie J.
Simons, Lee H.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2017, 284 (1860)
[33] Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: A population-level analysis
Chisholm, D
EPILEPSIA, 2005, 46 (05) : 751 - 759
[34] DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP)
Roebuck, MC
French, MT
McLellan, AT
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2003, 25 (01) : 51 - 57
[35] Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand
Thongsri, Watsamon
Bussabawalai, Thanaporn
Leelahavarong, Pattara
Wanitkun, Suthep
Durongpisitkul, Kritvikrom
Chaikledkaew, Usa
Teerawattananon, Yot
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (04) : 525 - 536
[36] A more integrative approach to better match treatments to long-term care residents: Preliminary results of a meta-analysis
Declercq, Ine
Leontjevas, Ruslan
Van Hooren, Susan
Gerritsen, Debby
INTERNATIONAL PSYCHOGERIATRICS, 2021, 33 : 65 - 66
[37] THE EFFECT OF THE DRUG LIFE CYCLE PRICE ON COST-EFFECTIVENESS RESULTS: A REAL-WORLD DATA ANALYSIS
Schottler, M.
Coerts, F.
Postma, M.
Boersma, C.
Rozenbaum, M.
VALUE IN HEALTH, 2022, 25 (01) : S109 - S109
[38] A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013
Phillip L. Marotta
Charlotte A. McCullagh
European Journal of Epidemiology, 2018, 33 : 679 - 688
[39] A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013
Marotta, Phillip L.
McCullagh, Charlotte A.
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2018, 33 (07) : 679 - 688
[40] Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
Yu Kondo
Tomoya Tachi
Takayoshi Sakakibara
Jun Kato
Takahito Mizuno
Yoshio Miyake
Hitomi Teramachi
Journal of Pharmaceutical Health Care and Sciences, 8

← 1 2 3 4 5 →